Outcomes for a large series of radical cystectomies for bladder cancer

European Journal of Surgical Oncology

Volumn 34, Issue 8, 2008, Pages 911-915

  Niu, H T ^a   Xu, T ^b   Zhang, Y B ^c   Pang, D Q ^d   Zhang, Z L ^a   Wu, S ^a   Cheng, B ^d   Wang, Y ^d   Chang, J W ^d   Sun, G ^d  

^a QINGDAO UNIVERSITY   (China)

^b 401 Hospital of PLA   (China)

^c NORTH CHINA COAL MEDICAL COLLEGE   (China)

^d Second Affiliated Hospital   (China)

Author keywords

Lymphadenectomy; Neoadjuvant chemotherapy; Prognostic factors; Radical cystectomy

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CHINA; CYSTECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PELVIS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 46749119440     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.01.010     Document Type: Article

References (18)

1. Madersbacher S., Hochreiter W., Burkhard F., et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21 (2003) 690-696
2. Dalbagni G., Genega E., Hashibe M., et al. Cystectomy for bladder cancer: a contemporary series. J Urol 165 (2001) 1111-1116
3. Lotan Y., Gupta A., Shariat S., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533-6539
4. Oosterlinck W., Lobel B., Jakse G., et al. European Association of Urology (EAU) Working Group on Oncological Urology. Guidelines on bladder cancer. Eur Urol 41 (2002) 105-112
5. Cam K., Yildirim A., Ozveri H., et al. The efficacy of neoadjuvant chemotherapy in invasive bladder cancer. Int Urol Nephrol 33 (2002) 49-52
6. Louie-Johnsun M.W., Braslis K.G., Murphy D.L., et al. Radical cystectomy for primary bladder malignancy: a 10 year review. ANZ J Surg 77 (2007) 265-269
7. Stein J.P. Improving outcomes with radical cystectomy for high-grade invasive bladder cancer. World J Urol 24 (2006) 509-516
8. Leissner J., Ghoneim M.A., Abol-Enein H., et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171 (2004) 139-144
9. Vazina A., Dugi D., Shariat S.F., et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 171 (2004) 1830-1834
10. Buscarini M., Josephson D.Y., and Stein J.P. Lymphadenectomy in bladder cancer: a review. Urol Int 79 (2007) 191-199
11. Stein J.P., and Skinner D.G. The role of lymphadenectomy in high-grade invasive bladder cancer. Urol Clin North Am 32 (2005) 187-197
12. Steven K., and Poulsen A.L. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J Urol 178 (2007) 1218-1224
13. Konety B.R., Joslyn S.A., and O'Donnell M.A. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the surveillance, epidemiology and end results program data base. J Urol 169 (2003) 946-950
14. Dreicer R. Chemotherapy for muscle-invasive bladder cancer in the perioperative setting: current standards. Urol Oncol 25 (2007) 72-75
15. Hosseini S.Y. Invasive bladder cancer: the role of bladder preserving therapy. Urol J 2 (2005) 1-7
16. Fernando S.A., and Sandler H.M. Multimodality bladder preservation therapy for muscle-invasive bladder tumors. Semin Oncol 34 (2007) 129-134
17. Sternberg C.N., Donat S.M., Bellmunt J., et al. Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology 69 (2007) 62-79
18. Ferreira U., Matheus W.E., Nardi Pedro R., et al. Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate. Urol Int 79 (2007) 200-203